Consultation
Roberto reviews your depression history, prior treatments, and goals to confirm Exomind fits your needs.
Exomind in Pembroke Pines, FL
Next-Generation TMS for Depression
Sessions:As few as 6
Session Time:Under 30 minutes
Technology:BTL ExoTMS with trapezoid waveform
Downtime:None
Understanding
When Depression Calls for Exomind Neuromodulation
Understanding Treatment-Resistant Depression
Depression that does not respond to medication can feel isolating and exhausting. Many patients cycle through two, three, or more antidepressants only to face ongoing fatigue, persistent low mood, difficulty concentrating, and disrupted sleep. Side effects like weight changes, emotional blunting, or sexual dysfunction often compound the burden. Traditional TMS can help, but the demands of 30 to 40 long sessions over 6 to 9 weeks keep many patients from completing a full course.
Exomind changes the treatment equation. Built on the same science as traditional TMS, it delivers a stronger, more focused magnetic field through a comfortable trapezoid waveform that most patients tolerate easily. A single session takes under 30 minutes, and a full course can be completed in as few as 6 visits. There are no medications, no anesthesia, and no downtime, so you can return to work, family, and daily life immediately after every session.
What Is Exomind?
The Science of Focused Neuromodulation
Exomind is an advanced non-invasive neuromodulation system developed by BTL that uses repetitive transcranial magnetic stimulation to treat major depressive disorder. It has received FDA clearance as a treatment for adult patients who have not achieved satisfactory improvement from prior antidepressant medications.
How Exomind Works
Exomind delivers focused magnetic pulses through a coil placed over the left dorsolateral prefrontal cortex, a brain region strongly linked to mood regulation. These pulses induce small electrical currents that stimulate underactive neural circuits, a process called long-term potentiation that gradually restores healthy brain activity. Clinical research on repetitive transcranial magnetic stimulation shows remission rates of approximately 30 to 40 percent and response rates above 50 percent in patients with medication-resistant depression.
Unlike traditional systems, Exomind uses a trapezoid waveform that distributes energy more evenly across the scalp. This reduces the sharp tapping sensation many patients associate with standard TMS. You can learn more about the technology directly from Exomind by BTL, the manufacturer behind the system. R&C Psychiatry also offers complementary TMS therapy and Spravato pathways for patients who need a different modality.
What Happens During Exomind Treatment
You relax in a treatment chair while the coil is positioned over your scalp. You remain fully awake and alert. Most patients describe a gentle tapping sensation and can read, watch television, or simply rest during the session. There is no sedation, no IV, and no recovery period afterward.
Exomind Results and Duration
Many patients notice improvements in mood, energy, and sleep within the first two to three weeks. Full therapeutic benefit is typically reached by the end of the treatment course. Clinical data suggest antidepressant effects from a completed course can last 6 to 12 months or longer, with optional maintenance sessions available.
Treatment Timeline
Brain Mapping
5 minutes at first visit
First Signs
2-3 weeks into treatment
Full Effect
By end of 6-session course
Treatment Time
Under 30 minutes per session
Recovery
None, immediate return to activities
Benefits of Exomind Treatment
Faster, More Comfortable Relief
- 01
Fewer Sessions
As few as 6 sessions compared to 30-40 with traditional TMS
- 02
Shorter Appointments
Under 30 minutes per session versus 40-60 minutes elsewhere
- 03
Gentle Trapezoid Waveform
Smoother, more comfortable scalp sensation than standard TMS
- 04
Rapid Brain Mapping
5-minute coil mapping instead of the typical 12-30 minutes
- 05
No Medication, No Downtime
Drug-free treatment that lets you resume activities immediately
- 06
Lasting Results
Durable antidepressant effects measured in months after treatment
Exomind vs. Alternatives
Compare Your Options
| System | Sessions | Session Length | Mapping Time | Waveform Comfort | FDA Status | Best For |
|---|---|---|---|---|---|---|
| Exomind | As few as 6 | Under 30 minutes | 5 minutes | Trapezoid, gentle | FDA cleared | Fast, comfortable relief |
| Traditional TMS (NeuroStar, etc.) | 30-40 | 40-60 minutes | 12-30 minutes | Standard, sharper tap | FDA cleared | Established protocols |
| Spravato | Twice weekly, then weekly | 2 hours with monitoring | Not applicable | Nasal spray, no coil | FDA approved | Rapid onset, TRD |
| Oral Antidepressants | Daily for months | Not applicable | Not applicable | Not applicable | FDA approved | First-line medication care |
Who Is a Good Candidate for Exomind?
Finding Your Best Mental Health Path
Exomind is designed for adults living with major depressive disorder who want a faster, more comfortable alternative to traditional neuromodulation or oral medication. During your consultation, our team reviews your medical history, prior treatments, and goals to determine whether Exomind, TMS therapy, or Spravato offers the best path forward.
Ideal Candidates for Exomind
- Adults 18 years and older diagnosed with major depressive disorder
- Patients who have not responded fully to one or more antidepressant medications
- Individuals seeking depression treatment without medication side effects
- Patients pursuing care for treatment-resistant depression
- Those who want fewer appointments and shorter session times than traditional TMS
- People in stable medical health who can commit to a short treatment course
Who Should Wait or Avoid Exomind
- Patients with implanted metallic or electronic devices near the head, such as cochlear implants or deep brain stimulators
- Individuals with a personal history of seizure disorder or uncontrolled epilepsy
- Those with active substance use that interferes with treatment safety
- Patients with unstable medical conditions requiring medical stabilization first
- Anyone who is pregnant or breastfeeding, until reviewed on a case-by-case basis
Final candidacy is always determined by the clinical team based on a comprehensive evaluation. According to the National Institute of Mental Health, repetitive transcranial magnetic stimulation is considered safe and effective when delivered by trained clinicians following published protocols.
What Happens During Exomind Treatment
Brain Mapping
Roberto completes a precise 5-minute motor threshold mapping to locate the optimal stimulation target.
Sessions
You receive as few as 6 focused Exomind sessions, each under 30 minutes with no sedation or downtime.
Progress Review
Our team tracks mood, sleep, and energy changes weekly using validated rating scales like the PHQ-9.
Maintenance
Optional maintenance sessions are scheduled to sustain long-term benefits once your course is complete.
Risks and Side Effects
What to Know
Common Exomind Side Effects
Most patients tolerate Exomind very well. The most frequently reported effects are mild scalp discomfort, light tapping sensations, and short-lived headache near the stimulation site. These typically resolve within minutes to hours of a session and tend to decrease with each subsequent treatment. Some patients also report brief facial muscle twitching or transient lightheadedness on standing.
Rare Complications
Serious complications are uncommon. The most clinically significant rare risk is seizure, reported at an estimated incidence of less than 1 in 30,000 sessions when published safety guidelines are followed. Transient hearing changes can occur if proper ear protection is not worn, which is why protective earplugs are provided at every session.
Safety and FDA Status
Exomind is FDA cleared for the treatment of major depressive disorder in adults who have not responded to prior antidepressant therapy. Additional information on FDA clearance for neuromodulation devices is published through the agency's neurological devices program. The R&C Psychiatry team follows published safety guidelines, including the International Federation of Clinical Neurophysiology TMS safety recommendations, to minimize risks at every visit.
Exomind Cost in Pembroke Pines
Pricing and Payment Options
Exomind pricing in Pembroke Pines, FL depends on the number of sessions prescribed, whether maintenance care is included, and your insurance coverage. A full 6-session Exomind course generally ranges from about $2,500 to $4,500 in South Florida, with individual session pricing available for maintenance visits. Exact pricing will be discussed during your consultation based on your individual treatment plan.
Insurance Coverage
Many commercial insurance plans cover TMS-based neuromodulation for adults with treatment-resistant depression. Our team will verify your benefits, submit any required prior authorizations, and review out-of-pocket responsibility before treatment begins.
Flexible Payment Options
If insurance does not fully cover your care, we offer transparent self-pay pricing and can discuss payment arrangements during your consultation.
- Self-Pay - Bundled session packages available at a reduced per-session rate
- HSA / FSA - Most Exomind visits are eligible for Health Savings and Flexible Spending Accounts
- Superbills - Provided for out-of-network insurance reimbursement when applicable
Why Choose R&C Psychiatry for Exomind in Pembroke Pines, FL
Pembroke Pines's Trusted Provider
Advanced Exomind Technology
Latest BTL ExoTMS platform with trapezoid waveform and rapid mapping
Experienced Providers
Spravato and TMS certified clinicians with decades of psychiatric experience
Integrated Care Model
Exomind coordinated with therapy, medication, and whole-person support
Bilingual English and Spanish
Compassionate, culturally responsive care for South Florida patients
Explore More
Related Services
Advanced Treatments
Psychiatric Care
Frequently Asked Questions About Exomind
Your Questions Answered
01 What is Exomind?
Exomind is an advanced FDA-cleared neuromodulation system by BTL that uses focused magnetic pulses to stimulate mood-regulating brain regions in adults with depression.
02 How is Exomind different from traditional TMS?
Exomind uses a trapezoid waveform, a stronger focused field, and a 5-minute mapping protocol, allowing courses as short as 6 sessions and visits under 30 minutes.
03 Is Exomind covered by insurance?
Many commercial plans cover neuromodulation for treatment-resistant depression. R&C Psychiatry verifies benefits and handles prior authorizations before you begin care.
04 How many Exomind sessions do I need?
Most patients complete care in as few as 6 sessions, compared with the 30-40 typical of traditional TMS. Some patients benefit from additional maintenance sessions.
05 Is Exomind FDA approved?
Exomind has FDA clearance for major depressive disorder in adults who have not responded to prior antidepressant medication, a standard regulatory pathway for neuromodulation devices.
06 Does Exomind work?
Clinical data on repetitive transcranial magnetic stimulation show response rates above 50 percent and remission rates near 30-40 percent in treatment-resistant depression.
07 Exomind vs TMS: which is right for me?
Exomind offers faster, more comfortable sessions, while traditional TMS has the longest track record. Your provider will recommend the best fit based on history and goals.
08 Can Exomind treat anxiety as well as depression?
Exomind is cleared for depression, but many patients with coexisting anxiety report mood and anxiety improvements. Your provider may combine Exomind with therapy for anxiety support.
Location9050 Pines Blvd, Suite 150
Pembroke Pines, FL, 33024
Pembroke Pines, FL, 33024
Phone(954) 872-0555
Schedule Your Exomind Consultation
References
- PubMed (PMID: 17573044) - O'Reardon et al., 2007: Multisite randomized controlled trial establishing efficacy and safety of repetitive transcranial magnetic stimulation for major depressive disorder.
- PubMed (PMID: 27090022) - Perera et al., 2016: Clinical TMS Society consensus review of rTMS protocols, safety, and outcomes in medication-resistant depression.
- PubMed (PMID: 25564076) - Levkovitz et al., 2015: Randomized multicenter trial showing deep TMS produces significant improvement in treatment-resistant depression versus sham stimulation.
- FDA Neurological Devices Program - Regulatory information on FDA-cleared neuromodulation systems for major depressive disorder.
- National Institute of Mental Health - Overview of brain stimulation therapies including rTMS for depression.